Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Reading the DNA of fetuses is the next frontier of the genome revolution. Do you really want to know the genetic destiny of your unborn child?
Companies count DNA sequences in the blood of high-risk moms to test for Down syndrome and other large-scale disruptions, but they could do more.
A new program takes the research out of genomics.
Illumina announces a new high-end sequencer made for “factory-scale” sequencing of human genomes.
Carrier screening can prevent disease in families, but some doubt that it can change population-level incidence of disease.
In 2012, genomics tiptoed into the doctor’s office, gene therapy rose again, and man and machine united.
Software that enables collaboration between labs could make it easier for doctors to translate genome information.
The promise of better drug design and genetic diagnoses spurs big pharma’s interest in sequencing technology.
After outflanking and outlasting competitors, it is on top of the genome-sequencing business—just as that market is about to soar in importance.
The findings demonstrate how genome analysis could guide health-care decisions for healthy people.